Tubular and glomerular damage markers in urine and blood samples in diabetic patients.

Tubular and glomerular damage markers in urine and blood samples in diabetic patients. - Tubular and glomerular damagemarkers

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON32838

Enrollment

100

Registered

2008-12-18

Start date

2009-03-23

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic nephropathy

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: age > 18 years diabetes mellitus albuminuria (40 patients with normo-albuminuria, 40 with micro-albuminuria and 20 with macro-albuminuria will be included)

Exclusion criteria

Exclusion criteria: lacking retinopathy when having albuminuria (micro or macro) primary renal disease other than diabetic nephropathy mentally incapacitated erythrocyturia (more than 25 per field of vision) Use of nephrotoxic medication

Design outcomes

Primary

Measure	Time frame
Study parameters are the concentration tubular and glomerular biomarkers and urine albumin excretion.	—

Secondary

Measure	Time frame
association with renal function (measured as eGFR) association with diabetes control (measured as HbA1c)	—

Countries

Netherlands

Outcome results